scispace - formally typeset
Y

Yapu Zhao

Researcher at Nankai University

Publications -  6
Citations -  158

Yapu Zhao is an academic researcher from Nankai University. The author has contributed to research in topics: Antigen & Natural killer T cell. The author has an hindex of 5, co-authored 6 publications receiving 121 citations. Previous affiliations of Yapu Zhao include Tianjin Medical University.

Papers
More filters
Journal ArticleDOI

Vγ4 γδ T Cell-Derived IL-17A Negatively Regulates NKT Cell Function in Con A-Induced Fulminant Hepatitis

TL;DR: A novel function of Vγ4 γδ T cells is demonstrated in mediating a protective effect against Con A-induced fulminant hepatitis through negatively regulating function of NKT cells in an IL-17A–dependent manner, and transferring Vγ 4 γ Δ T cells may provide a novel therapeutic approach for this devastating liver disease.
Journal ArticleDOI

Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses.

TL;DR: This very uniform hybrid Alum particulate system could have important application as a vaccine carrier to stimulate humoral and cellular immune responses at the same time.
Journal ArticleDOI

A novel antigen delivery system induces strong humoral and CTL immune responses.

TL;DR: Treatment with β-glucan particles significantly prevented the growth of implanted EG7-OVA tumors in a prophylactic and pre-established tumor model, suggesting that this strategy may be able to be utilized as a promising platform for cancer immunotherapy.
Journal ArticleDOI

ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth

TL;DR: Patients with activated NF-κB signaling should be given priority for enrollment in future phase II clinical trials, as the underlying mechanisms of a new orphan drug, ACT001, significantly suppressed glioma cell proliferation and induced apoptosis and cell cycle arrest in vitro.
Journal ArticleDOI

IL-4 induces a suppressive IL-10-producing CD8+ T cell population via a Cdkn2a-dependent mechanism.

TL;DR: A population of IL‐10‐producing CD8+ Tregs induced by IL‐4 and mediated by Cdkn2a is defined, indicating a critical role of this population of CD8- T cells in regulatory immune responses.